reference/34193129

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34193129

Outgoing Links

Predicate	Object
contentType	Journal Article\|Multicenter Study\|Randomized Controlled Trial
endingPage	390
issn	1533-712X 0271-0749
issueIdentifier	4
pageRange	383-390
publicationName	Journal of Clinical Psychopharmacology
startingPage	383
bibliographicCitation	Wang D, Wei N, Hu F, Li J, Wang Y, Qian Z, Yang M, Yao M, Xia Y, Yu H, Tu W, Ye M, Qian C, Hu J, Chen J, Hu C, Huang M, Xu Y, Hu S. Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Multicenter Study. J Clin Psychopharmacol. 2022 Jul;42(4):383–90. doi: 10.1097/jcp.0000000000001573. PMID: 35695720.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_36f561dfe1cf75c54ff8c7f3e08395e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce157678e2e61afe791082602b972fbc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29d615ef87266095633b24baabcdd3c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6a46ff00827d4a1af29510783d6e219 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fb62fa3c5487c9f93f309a3fff2a150 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da01ce78b0bc3205178dce5ca9d1648e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b1e58697d764dd5e73fea30236f371f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_554053cfcf288438a7babdb1970bca40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_41c1878eda8c2b4e0e1931c7c7dc5f83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51b264eab94297164512bf10a67af716 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_93627536ca8a24a809f7ebf8d7469ff3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4681dcc5d9c137dface6036ce7267a57 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a1b7ca33190dd7f7a37a1a2fd6d76b22 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b7da0c2bfb98428d6bd2b6193b054bb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c5ced79a7522af7b96db566a9641267c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1146b9470e093af400536619b810dce2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_044eeb8b3634be6d1f92eba0db0d31b3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e7a79cc6f42ded8c6ab504a9b1881645 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d2563709c15dc160d0c24d9cf45694d
date	2022-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/35695720 https://doi.org/10.1097/jcp.0000000000001573
isPartOf	https://portal.issn.org/resource/ISSN/1533-712X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4660 https://portal.issn.org/resource/ISSN/0271-0749
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia: A Randomized, Double-Blind, Multicenter Study
discusses	http://id.nlm.nih.gov/mesh/M0204623 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0021770 http://id.nlm.nih.gov/mesh/M0546009 http://id.nlm.nih.gov/mesh/M0005772 http://id.nlm.nih.gov/mesh/M0011807
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014150Q000009 http://id.nlm.nih.gov/mesh/D012559Q000188 http://id.nlm.nih.gov/mesh/D012559Q000175
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000068882 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011743 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D007555Q000009 http://id.nlm.nih.gov/mesh/D003692Q000627 http://id.nlm.nih.gov/mesh/D000077152Q000009 http://id.nlm.nih.gov/mesh/D000090663
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9709 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115237 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398745 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9013 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9168

Total number of triples: 61.